InvestorsHub Logo
Followers 7
Posts 1572
Boards Moderated 0
Alias Born 10/01/2006

Re: None

Monday, 08/27/2007 9:29:19 AM

Monday, August 27, 2007 9:29:19 AM

Post# of 9504
On The Go Granted Exclusive Partnership With Medical Imaging Technology Leader
Monday August 27, 9:00 am ET


CONCORD, Ontario, Aug. 27 /PRNewswire-FirstCall/ -- On The Go Technologies Group (OTC Bulletin Board: ONGO; 'OTG' 'the Company'), a leading multi- industry computer hardware, software and systems integrator, announced today that the Company has completed negotiations with an industry leader in breakthrough software technology in the field of 2D/3D medical diagnostics, to be their exclusive distribution partner in Canada. OTG will further have access to the product in the United States.
ADVERTISEMENT


The New York based affiliate's pioneering software technology provides physicians a quantum leap in diagnostic tools, both extending lives by enabling non-invasive and accurate visualization for medical problems found within various organs of the body and lowering the net cost of providing health care worldwide.

Their V3D-Colon is the market leader in virtual colonoscopy software. Although colorectal cancer, the second leading cause of cancer related deaths, has a prevention rate of over 90% when pre-cancerous polyps are detected early, an estimated 80-85% of the population is never screened, due in large part to the discomfort, sedation and risk factors of conventional optical colonoscopy. Imaging Economics, one of the industry's most recognized imaging technology journals recently stated in great support of such virtual testing, "Current state-of-the art [screening], including 3D polyp detection and oral contrast tagging, is at least as sensitive as the purported 'gold standard' optical colonoscopy for clinically relevant polyps. In fact, if done right, [we] believe it is the most sensitive test for detecting advanced neoplasia."

The firm's V3D-Calcium Scoring and V3D-Explorer, the firm's the next generation sophisticated technology, is also available for OTG's distribution. Using digital data generated by Computed Tomography (CT), Magnetic Resonance (MRI) and other digital scanners, Viatronix's goal is to provide medical professionals with a means to virtually explore the entirety of the inside the human body, detecting potentially serious abnormalities or disease, extending patients' lives as well as lowering the net cost of providing healthcare worldwide.

CEO Stuart Turk stated, "This partnership is one that puts OTG Healthcare at the forefront, and on the cutting edge, of virtual medical diagnostics. With a growing number of hospitals and clinics adding virtual technology to their testing rounds, not to mention more and more of an aging Baby Boomer generation of patients requesting the non-invasive procedures, the sales potential for the Company in both Canada and the US is a very lucrative one."